New Matter: Inside the Minds of SLAS Scientists

A Critical Platform

May 10, 2021 SLAS Episode 81
New Matter: Inside the Minds of SLAS Scientists
A Critical Platform
Show Notes

Join Ross Lagoy  and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease.